title: [The use of the hypoglycemic preparation gliquidone in patients with digestive organ diseases combined with diabetes mellitus].
abstract: A peroral sugar-reducing preparation gliquidone (glurenorm) was tried in treatment of 66 patients with digestive diseases (peptic ulcer, chronic pancreatitis, cirrhosis of the liver), presenting with diabetes mellitus. The results of the studies made showed glurenorm to be a highly effective preparation in term of both its sugar-reducing effect and its capability to improve energy processes in gastric and duodenal mucosa, pancreacytes, hepatocytes, besides which, it appear to dispel metabolic disturbances and stimulate reparative processes in body organs, improves protein-synthetic processes in the liver, pancreas, mucosa of the gastroduodenal region.
authors.forename: I I
authors.initials: II
authors.lastname: Degtiareva
authors.forename: E V
authors.initials: EV
authors.lastname: Lodianaia
authors.forename: N D
authors.initials: ND
authors.lastname: Opanasiuk
authors.forename: O L
authors.initials: OL
authors.lastname: Palladina
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D004066:Digestive System Diseases / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005750:Gastric Juice / Q000187:drug effects; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D012074:Remission Induction; D013453:Sulfonylurea Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds; C010969:gliquidone